{{Rsnum
|rsid=1805377
|Gene=XRCC4
|Chromosome=5
|position=83353124
|Orientation=plus
|GMAF=0.3939
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=XRCC4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 25.9 | 74.1
| HCB | 48.2 | 43.8 | 8.0
| JPT | 38.1 | 51.3 | 10.6
| YRI | 21.9 | 49.3 | 28.8
| ASW | 19.3 | 54.4 | 26.3
| CHB | 48.2 | 43.8 | 8.0
| CHD | 53.2 | 36.7 | 10.1
| GIH | 1.0 | 27.7 | 71.3
| LWK | 27.3 | 50.0 | 22.7
| MEX | 15.5 | 41.4 | 43.1
| MKK | 19.2 | 51.3 | 29.5
| TSI | 1.0 | 21.0 | 78.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19408343
|Title=Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study
}}

{{PMID Auto
|PMID=21617942
|Title=Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer
}}

{{PMID Auto
|PMID=22659345
|Title=Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B: possible implications on survival
}}

{{PMID|16465622|OA=1
}} Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

{{PMID|16857995|OA=1
}} Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes.

{{PMID|17557904}} Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.

{{PMID|18164646}} A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients.

{{PMID|18579371|OA=1
}} Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions.

{{PMID|18630527}} Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan.

{{PMID|18768505|OA=1
}} Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway.

{{PMID|19276285|OA=1
}} Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer.

{{PMID|21506695}} Do polymorphisms in XRCC4 influence prostate cancer susceptibility in North Indian population?

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}